Vimarsana
Biggest News Aggregation in the World

Page 3 - Plexium Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Plexium Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Plexium Inc Today - Breaking & Trending Today

AMGEN REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS - Vimarsana News

AMGEN REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 2022. Key results include: Total revenues decreased 1% to $6.7...

AMGEN REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS - Vimarsana News

AMGEN REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the second quarter of 2022. Key results include: Total revenues increased 1% to $6.6...

Amgen (NASDAQ:AMGN) vs. Aligos Therapeutics (NASDAQ:ALGS) Head to Head Contrast - Vimarsana News

Amgen (NASDAQ:AMGN) vs. Aligos Therapeutics (NASDAQ:ALGS) Head to Head Contrast

Aligos Therapeutics (NASDAQ:ALGS – Get Rating) and Amgen (NASDAQ:AMGN – Get Rating) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings and dividends. Volatility and Risk Aligos Therapeutics has a beta of 3.52, indicating […]

Abbvie and Plexium Enter Into Multi-Target Strategic Collaboration To Develop and Commercialize Targeted Protein Degradation Therapies for Neurological Conditions - Vimarsana News

Abbvie and Plexium Enter Into Multi-Target Strategic Collaboration To Develop and Commercialize Targeted Protein Degradation Therapies for Neurological Conditions

/PRNewswire/ -- Plexium, Inc. (Plexium) and AbbVie (NYSE: ABBV) have entered into an exclusive strategic collaboration to develop and commercialize novel...

AMGEN REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS - Vimarsana News

AMGEN REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS

/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced financial results for the first quarter of 2022. Key results include: Total revenues increased 6% to $6.2...